Stoke Therapeutics, Inc. (STOK)
USD 11.11
(-8.18%)
USD 11.11
(-8.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -81.06 Million | -31.86 Million | -66.9 Million | -42.22 Million | -31.05 Million | -10.96 Million |
| Net Income | -104.69 Million | -101.06 Million | -85.8 Million | -52.24 Million | -32.32 Million | -12.52 Million |
| Depreciation & Amortization | 4.72 Million | 1.54 Million | 974 Thousand | 888 Thousand | 450 Thousand | 214 Thousand |
| Deferred income taxes | 3.2 Million | - | 172 Thousand | 3000.00 | - | - |
| Stock-based compensation | 25.25 Million | 22.85 Million | 16.45 Million | 5.76 Million | 1.92 Million | 240 Thousand |
| Change in working capital | -6.03 Million | 43.02 Million | 46 Thousand | 2.32 Million | -1.1 Million | 1.09 Million |
| Other non-cash items | -3.53 Million | 1.77 Million | 1.25 Million | 1.03 Million | 3000.00 | 10 Thousand |
| Investing Cash Flow | 105.94 Million | -45.88 Million | -76.42 Million | -1.05 Million | -1.63 Million | -925 Thousand |
| Investments in PPE | -1.61 Million | -3.96 Million | -1.2 Million | -1.05 Million | -1.63 Million | -935 Thousand |
| Acquisitions | - | 45.34 Million | 75.22 Million | - | 1000.00 | 10 Thousand |
| Investment purchases | - | -201.32 Million | -87.22 Million | - | - | - |
| Sales/Maturities of investments | 107.56 Million | 159.4 Million | 12 Million | - | - | - |
| Other Investing Activities | 107.56 Million | -45.34 Million | -75.22 Million | - | 1000.00 | 10 Thousand |
| Financing Cash Flow | 53 Million | 46.4 Million | 1.28 Million | 108.1 Million | 149.76 Million | 115.63 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 53 Million | 46.4 Million | 1.28 Million | 105.39 Million | 151.91 Million | 115.64 Million |
| Other Financing Activities | 53 Million | 46.4 Million | -2000.00 | 2.71 Million | -2.15 Million | 115.63 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3.2 Million | 121 Thousand | 2.89 Million | 5.2 Million | 891 Thousand | 1.73 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.82 Million | 42.9 Million | -2.85 Million | -2.87 Million | -1.99 Million | 1.09 Million |
| Cash at beginning of period | 113.55 Million | 145.46 Million | 287.51 Million | 222.67 Million | 105.6 Million | 1.85 Million |
| Cash at end of period | 191.44 Million | 114.12 Million | 145.46 Million | 287.51 Million | 222.67 Million | 105.6 Million |
| Capital Expenditure | -1.61 Million | -3.96 Million | -1.2 Million | -1.05 Million | -1.63 Million | -935 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 77.88 Million | -31.33 Million | -142.04 Million | 64.83 Million | 117.07 Million | 103.75 Million |
| Free Cash Flow | -82.68 Million | -35.82 Million | -68.1 Million | -43.27 Million | -32.69 Million | -11.89 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -26.43 Million | -25.69 Million | -26.37 Million | -104.69 Million | -26.95 Million | -24.54 Million |
| Depreciation & Amortization | -572 Thousand | 1.11 Million | 1.11 Million | 4.72 Million | 1.21 Million | 637 Thousand |
| Deferred income taxes | - | - | - | 3.2 Million | -9.63 Million | -121 Thousand |
| Stock-based compensation | 7.49 Million | 7.42 Million | 5.41 Million | 25.25 Million | 6.05 Million | 6.55 Million |
| Change in working capital | 4.72 Million | -30 Thousand | -4.69 Million | -6.03 Million | -875 Thousand | -351 Thousand |
| Other non-cash items | -6.82 Million | 5.78 Million | 9.53 Million | -3.53 Million | 9.54 Million | 563 Thousand |
| Investing Cash Flow | -30 Million | -88.27 Million | 9.98 Million | 105.94 Million | 14.77 Million | 14.61 Million |
| Investments in PPE | -103 Thousand | -46 Thousand | -12 Thousand | -1.61 Million | -229 Thousand | -383 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -49.9 Million | -88.23 Million | - | - | - | - |
| Sales/Maturities of investments | 20 Million | - | 10 Million | 107.56 Million | 15 Million | 15 Million |
| Other Investing Activities | - | -88.23 Million | 10 Million | 107.56 Million | 15 Million | 15 Million |
| Financing Cash Flow | 8.15 Million | 120.65 Million | 1.71 Million | 53 Million | 7.34 Million | 562 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -113.41 Million | 120.65 Million | 1.71 Million | 53 Million | 7.34 Million | 562 Thousand |
| Other Financing Activities | 121.57 Million | 766 Thousand | 1.71 Million | 53 Million | 7.34 Million | 562 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -749 Thousand | 3.57 Million | -1.91 Million | -3.2 Million | -1.14 Million | 2.01 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 6.37 Million | -3.6 Million | -2.77 Million | -2.82 Million | 274 Thousand | -2.36 Million |
| Cash at beginning of period | 193.55 Million | 178.58 Million | 191.44 Million | 113.55 Million | 189.97 Million | 192.62 Million |
| Cash at end of period | 150.58 Million | 193.55 Million | 178.58 Million | 191.44 Million | 191.44 Million | 190.54 Million |
| Capital Expenditure | -103 Thousand | -46 Thousand | -12 Thousand | -1.61 Million | -229 Thousand | -383 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -42.96 Million | 14.97 Million | -12.86 Million | 77.88 Million | 1.46 Million | -2.08 Million |
| Free Cash Flow | -21.71 Million | -17.52 Million | -24.57 Million | -82.68 Million | -20.87 Million | -17.64 Million |
BOI
LTIM
INDUSINDBK
DILD
PIC
OILCF